TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
TMCI

Treace Medical Concepts Inc

Healthcare · Medical Devices

4.50$ -0.7% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Treace Medical Concepts Inc (TMCI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 73.6% of the shares are freely tradable; institutional investors hold 57.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 57.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 25.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 73.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 3.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 65Mio.

Largest Shareholders

Institutions

Institutions TMCI
Name Stake (%) Shares Change (%) Date
Armistice Capital, LLC 9.79 6,364,000 +0.0 03/31/2026
BlackRock Inc 5.14 3,340,023 -2.1 03/31/2026
Bank of America Corp 4.94 3,214,293 +38.9 03/31/2026
Gagnon Securities LLC 4.66 3,029,543 -41.8 06/30/2026
Gagnon Advisors, LLC 2.36 1,534,034 +0.0 06/30/2026
Vanguard Capital Management, LLC 2.25 1,461,507 +0.0 03/31/2026
State Street Corp 1.90 1,235,518 +24.3 03/31/2026
CIBC Bancorp USA Inc. 1.87 1,218,353 +0.0 03/31/2026
AQR Capital Management LLC 1.63 1,061,840 +0.0 03/31/2026

Funds

Funds TMCI
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.23 1,447,595 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings TMCI
Person Role Shares Value As of Type
Treace John T. Chief Executive Officer 7,404,383 33,319,724 $ Aug 24, 2026 direct
Hair Mark Chief Financial Officer 914,900 4,117,050 $ Aug 9, 2026 direct
Elder Scot Michael Chief Legl & Comp Off, CorpSec 778,683 3,504,074 $ Aug 9, 2026 direct
Scanlan Sean F. Chief Innovation Officer 679,863 3,059,384 $ Aug 9, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 24, 2026 Treace John T. Chief Executive Officer Buy 11,000 4.34 47,731
Aug 21, 2026 Treace John T. Chief Executive Officer Buy 5,000 4.35 21,748
Aug 20, 2026 Treace John T. Chief Executive Officer Buy 39,944 4.44 177,176
Aug 9, 2026 Scanlan Sean F. Chief Innovation Officer Other 9,814 0.00
Aug 9, 2026 Hair Mark Chief Financial Officer Other 37,102 0.00
Aug 9, 2026 Elder Scot Michael Chief Legl & Comp Off, CorpSec Other 16,253 0.00

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?